Debt-to-EBITDA measures a company's ability to pay off its debt.
Becton, Dickinson and Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $1,682 Mil. Becton, Dickinson and Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $14,683 Mil. Becton, Dickinson and Co's annualized EBITDA for the quarter that ended in Jun. 2022 was $4,216 Mil.
Becton, Dickinson and Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 was 3.88.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Becton, Dickinson and Co's Debt-to-EBITDA or its related term are showing as below:
BDX'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.79 Med: 4.63 Max: 7.3
Current: 3.24
During the past 13 years, the highest Debt-to-EBITDA Ratio of Becton, Dickinson and Co was 7.30. The lowest was 1.79. And the median was 4.63.
BDX's Debt-to-EBITDA is ranked worse than 76.27% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 1.08
vs BDX: 3.24
Becton, Dickinson and Co Debt-to-EBITDA Historical Data
The historical data trend for Becton, Dickinson and Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Becton, Dickinson and Co Annual Data
Trend
Sep12
Sep13
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Debt-to-EBITDA
7.30
5.57
4.77
4.89
3.53
Becton, Dickinson and Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Debt-to-EBITDA
4.31
3.06
3.16
3.94
3.88
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton, Dickinson and Co Debt-to-EBITDA Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Becton, Dickinson and Co's Debt-to-EBITDA falls into.
Becton, Dickinson and Co Debt-to-EBITDA Calculation
Debt-to-EBITDA measures a company's ability to pay off its debt.
Becton, Dickinson and Co's Debt-to-EBITDA for the fiscal year that ended in Sep. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2022) EBITDA data.
Becton, Dickinson and Co (NYSE:BDX) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Becton, Dickinson and Co Debt-to-EBITDA Related Terms
Thank you for viewing the detailed overview of Becton, Dickinson and Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
3.12(1.18%) Volume: 774,242 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BDX has been successfully added to your 
